The West Virginia Independent Pharmacy Association praised West Virginia Offices of the Insurance Commissioner for holding ...
The Federal Trade Commission (FTC) may be nearing settlements with the remaining two pharmacy benefit managers involved in a lawsuit over insulin pricing. | The Federal Trade Commission may be nearing ...
Opinion: A settlement agreement between and Federal Trade commission and Express Scripts may prove more transformative than any single pricing overhaul because it has restructured the rebate-driven ...
This article examines the PBM-related provisions in the 2026 Consolidated Appropriations Act in the context of other federal and state efforts to regulate PBMs, then offers recommendations on ...
Lower drug prices offered through direct-to-consumer websites like TrumpRx are failing to reach patients with commercial ...
A Settlement, Not a Sigh of Relief: What the FTC’s Express Scripts Deal Signals for Enforcement Risk
The FTC’s newly announced settlement with Express Scripts marks a pivotal moment in the government’s campaign against pharmacy benefit manager pricing practices—and it should be read as more than a ...
Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...
Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. Today, Bernstein Litowitz Berger & Grossmann LLP (BLB&G) ...
The Federal Trade Commission secured a landmark settlement with one of the nation's largest pharmacy benefit managers ("PBMs"), Express Scripts, Inc., and its affiliated entities (collectively "ESI").
The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results